Beckley Psytech
Latest round
- Series B
Last raised
- Jul 2021
Total raised
- $88M
Investors
- 13
About Beckley Psytech
Founded in 2019 and based in Oxford, UK, Beckley Psytech Ltd. researches and develops psychedelic medicines for patients with mental and neurological diseases in need of neuropsychiatric treatments. In January 2024, Beckley Psytech Ltd.V. The company's research pipeline includes formulations and applications of psychedelic compounds such as 5-MeO-DMT and psilocin. The company is advancing these compounds through clinical trials for conditions including Major Depressive Disorder (MDD), Treatment Resistant Depression (TRD), and Alcohol Use Disorder (AUD). Their approach integrates personalized psychological support and digital tools to enhance therapeutic outcomes.
Who invested in Beckley Psytech
13 investors across 3 rounds
See all investors in Beckley Psytech
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Beckley Psytech
Who invested in Beckley Psytech?
Beckley Psytech has 13 investors on record across 3 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Beckley Psytech raised?
Beckley Psytech has raised 3 venture rounds. Sign up free to see how much each round raised and the total.
When did Beckley Psytech last raise money?
Beckley Psytech's most recent round on record is a Series B, in Jul 2021.
What does Beckley Psytech do?
Founded in 2019 and based in Oxford, UK, Beckley Psytech Ltd.
Where is Beckley Psytech headquartered?
Beckley Psytech is headquartered in Oxford, UK.
Which VCs invest in companies like Beckley Psytech?
Among active investors with capital left to deploy, Index Ventures, Forbion, European Investment Bank and Generation Investment Management back pharmaceuticals companies at Beckley Psytech's stage. Their profiles are linked below.
VCs backing pharmaceuticals startups at Series B
Raising like Beckley Psytech? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.